Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Boai NKY Medical (300109)
- 18.92
- -0.01-0.05%
Market Closed Apr 30 15:00 CST
9.15BMarket Cap52.41P/E (TTM)
19.15High18.70Low79.89KlotVolume18.90Open18.93Prev Close151.10MTurnover1.79%Turnover Ratio48.14P/E (Static)483.38MShares21.1152wk High2.47P/B8.46BFloat Cap14.6352wk Low22.72Limit Up447.26MShs Float59.72Historical High15.14Limit Down2.38%Range %1.19Historical Low0.25Dividend TTM18.91Avg Price37.78KlotAsk1.32%Div Yield TTM100Lot Size39.49KlotBid
Boai NKY Medical (300109) Income Statement
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 5.29%342.04M | -26.66%1.18B | -14.36%951.5M | -12.36%644.01M | -17.69%324.86M | 1.45%1.61B | -7.92%1.11B | -5.68%734.8M | 8.73%394.69M | 6.58%1.58B |
| Operating revenue | 5.29%342.04M | -26.66%1.18B | -14.36%951.5M | -12.36%644.01M | -17.69%324.86M | 1.45%1.61B | -7.92%1.11B | -5.68%734.8M | 8.73%394.69M | 6.58%1.58B |
| Other operating revenue | ---- | -36.87%11.88M | ---- | 18.35%3.11M | ---- | -10.10%18.81M | ---- | -54.46%2.63M | ---- | -42.91%20.93M |
| Total operating cost | 8.60%268.86M | -20.43%886.74M | 0.33%725.43M | 5.19%489.9M | 1.80%247.56M | 12.19%1.11B | 5.92%723.05M | 4.89%465.72M | 17.00%243.19M | -2.23%993.25M |
| Operating cost | 6.32%193.18M | -25.02%638.97M | 0.88%536.83M | 11.41%367.23M | -1.03%181.69M | 23.68%852.17M | 10.05%532.12M | 2.15%329.61M | 21.75%183.57M | -13.34%689.03M |
| Operating tax surcharges | 24.25%4.03M | -26.24%12.51M | -28.13%8.63M | -31.23%6.07M | -26.56%3.24M | 21.48%16.97M | 23.63%12M | 88.73%8.83M | 89.75%4.41M | 45.53%13.97M |
| Operating expense | 10.45%12.58M | -2.04%56.75M | -0.31%39.33M | 2.64%27.43M | -5.85%11.39M | -14.24%57.93M | -20.41%39.45M | -17.22%26.72M | -19.78%12.1M | 3.60%67.55M |
| Administration expense | -4.81%34.54M | -27.20%108.09M | -14.03%92.73M | -10.34%64.33M | 12.37%36.29M | -11.73%148.48M | -7.40%107.87M | -5.71%71.75M | 8.19%32.29M | 36.95%168.21M |
| Financial expense | 209.99%7.23M | 90.55%-3.09M | 23.73%-7.47M | -133.22%-16.67M | -130.94%-6.57M | -255.08%-32.69M | 35.98%-9.79M | 53.76%-7.15M | -122.15%-2.85M | 78.33%-9.21M |
| -Interest expense (Financial expense) | 9.42%2.19M | 7.72%7.59M | 26.37%4.43M | 48.55%3.6M | 77.71%2.01M | 240.67%7.04M | 15.15%3.5M | 23.94%2.43M | 20.76%1.13M | -21.03%2.07M |
| -Interest Income (Financial expense) | 28.06%-2.99M | 69.10%-11.12M | -14.27%-10.24M | 0.49%-7.31M | -8.75%-4.16M | -164.76%-35.99M | 25.94%-8.96M | 12.16%-7.34M | 13.56%-3.82M | 42.23%-13.59M |
| Research and development | -19.66%17.3M | 2.79%73.5M | 33.76%55.38M | 15.43%41.5M | 57.65%21.53M | 12.25%71.51M | 7.12%41.4M | 51.51%35.95M | 23.08%13.66M | -3.08%63.71M |
| Credit Impairment Loss | -111.62%-146.41K | 17.90%-26.98M | 115.12%1.97M | 105.84%527.13K | 139.44%1.26M | -172.67%-32.86M | -37.63%-13.05M | -17.67%-9.02M | -191.02%-3.2M | 76.25%-12.05M |
| Asset Impairment Loss | ---- | 16.26%-41.01M | ---- | ---- | ---- | ---48.97M | ---- | ---- | ---- | ---- |
| Other net revenue | -80.38%2.66M | 36.27%-53.2M | 189.81%20.21M | 204.91%13.86M | 266.04%13.54M | -1,593.98%-83.48M | -236.60%-22.5M | -436.38%-13.21M | -1,797.07%-8.15M | 93.92%-4.93M |
| Fair value change income | -115.74%-1.58M | 121.27%2.81M | 218.63%12.61M | 138.86%2.18M | 258.26%10.04M | -700.25%-13.22M | -312.28%-10.63M | -699.14%-5.6M | -468.32%-6.34M | 106.23%2.2M |
| Invest income | ---- | -52.42%468.96K | 8.05%-6.99M | 100.73%34.65K | ---- | 130.16%985.72K | -452.88%-7.6M | -382.78%-4.74M | ---- | -30.67%-3.27M |
| Asset deal income | 176,297.22%292.1K | 2,751.31%2.46M | 7,299.60%6.03M | 51,116.34%5.96M | 103.32%165.59 | 94.57%86.31K | 245.91%81.52K | 153.03%11.63K | -542.19%-4.98K | 105.12%44.36K |
| Other revenue | 82.46%4.09M | -13.88%9.04M | -24.25%6.58M | -16.07%5.16M | 61.51%2.24M | 28.93%10.5M | 29.27%8.69M | 16.56%6.15M | -56.04%1.39M | -2.78%8.14M |
| Operating profit | -16.51%75.85M | -41.70%238.15M | -32.61%246.29M | -34.35%167.97M | -36.63%90.84M | -30.20%408.48M | -29.34%365.44M | -23.05%255.88M | -7.36%143.35M | 50.57%585.24M |
| Add:Non operating Income | -96.96%35.82K | 46.92%1.28M | 10.86%2.3M | 38.94%1.68M | 788.11%1.18M | -29.98%869.88K | -4.20%2.08M | 58.50%1.21M | -81.42%132.75K | -29.52%1.24M |
| Less:Non operating expense | 1,063.11%434.95K | -62.62%3.02M | -76.07%1.47M | -91.09%376.89K | -93.59%37.4K | 623.50%8.08M | 1,196.82%6.16M | 1,400.04%4.23M | 892.94%583.06K | -43.16%1.12M |
| Total profit | -17.98%75.45M | -41.08%236.41M | -31.62%247.11M | -33.05%169.28M | -35.63%91.98M | -31.45%401.26M | -30.36%361.36M | -24.07%252.86M | -8.04%142.9M | 50.68%585.36M |
| Less:Income tax cost | -16.77%10.16M | -9.94%50.66M | -3.86%47.48M | -19.98%31.42M | -44.43%12.21M | -43.51%56.25M | -57.88%49.38M | -46.72%39.27M | -39.09%21.97M | -6.97%99.57M |
| Net profit | -18.16%65.28M | -46.16%185.75M | -36.01%199.64M | -35.46%137.85M | -34.03%79.77M | -28.98%345.01M | -22.33%311.98M | -17.63%213.59M | 1.35%120.92M | 72.61%485.79M |
| Net profit from continuing operation | -18.16%65.28M | -46.16%185.75M | -36.01%199.64M | -35.46%137.85M | -34.03%79.77M | -28.98%345.01M | -22.33%311.98M | -17.63%213.59M | 1.35%120.92M | 72.61%485.79M |
| Less:Minority Profit | 182.26%533.88K | 7.05%-4.34M | -297.31%-1.45M | -267.84%-1.1M | -40.34%-649K | 35.53%-4.67M | 122.56%736.19K | 122.71%656.78K | 30.58%-462.43K | 27.80%-7.24M |
| Net profit of parent company owners | -19.49%64.75M | -45.64%190.09M | -35.39%201.09M | -34.74%138.96M | -33.75%80.42M | -29.07%349.68M | -23.13%311.24M | -18.79%212.93M | 1.17%121.39M | 69.16%493.03M |
| Earning per share | ||||||||||
| Basic earning per share | -23.53%0.13 | -46.58%0.39 | -37.88%0.41 | -35.56%0.29 | -32.00%0.17 | -30.48%0.73 | -22.35%0.66 | -18.18%0.45 | -35.90%0.25 | 19.32%1.05 |
| Diluted earning per share | -23.53%0.13 | -45.83%0.39 | -36.92%0.41 | -34.09%0.29 | -32.00%0.17 | -29.41%0.72 | -21.69%0.65 | -18.52%0.44 | -32.43%0.25 | 20.00%1.02 |
| Other composite income | 118.88%401.38K | -191.95%-2.83M | -5,900.14%-2.5M | -1,131.32%-2.13M | 210.08%3.08M | -102.31%-41.66K | -211.13%-172.64K | -130.98%-2.8M | ||
| Other composite income of parent company owners | 118.88%401.38K | -191.95%-2.83M | -5,900.14%-2.5M | ---- | -1,131.32%-2.13M | 210.08%3.08M | -102.31%-41.66K | ---- | -211.13%-172.64K | -130.98%-2.8M |
| Total composite income | -15.40%65.69M | -47.45%182.91M | -36.80%197.14M | -35.46%137.85M | -35.70%77.65M | -27.93%348.09M | -22.68%311.94M | -17.63%213.59M | 1.07%120.75M | 66.28%482.99M |
| Total composite income of parent company owners | -16.79%65.15M | -46.92%187.25M | -36.19%198.59M | -34.74%138.96M | -35.41%78.29M | -28.04%352.76M | -23.49%311.2M | -18.79%212.93M | 0.90%121.21M | 63.14%490.23M |
| Total composite income of minority owners | 182.26%533.88K | 7.05%-4.34M | -297.31%-1.45M | -267.84%-1.1M | -40.34%-649K | 35.53%-4.67M | 122.56%736.19K | 122.71%656.78K | 30.58%-462.43K | 27.80%-7.24M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Zhongqin Wanxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm